All posts by : Felistas

Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated the safety and immunogenicity of an oral norovirus vaccine tablet, VXA-G1.1-NN. Results indicate that the vaccine was safe and well tolerated while eliciting robust systemic and mucosal immune responses in adults aged 55 to 80 years.

In updated consensus recommendations published online March 4 in the American Journal of Gastroenterology, additional guidance is presented for optimizing bowel preparation quality for colonoscopy.

Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March 4 in JAMA Network Open.

Subtle changes in the brain during pregnancy may help explain why some women develop postpartum depression.

Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy.

A study conducted by researchers at the University of Tartu showed a nearly five-fold enrichment of hereditary cancer variants in infertile men compared to fertile men.

Treatment for meningiomas, the most common type of brain tumor, is now safer thanks to technological advancements. At Mayo Clinic, navigation tools and precision imaging help surgeons operate with greater accuracy, improving patient outcomes.

Three new Ebola cases have been reported in Uganda, bringing the total to 12 since the outbreak began in late January, the African Union’s health agency said Thursday.

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by regulating hepatic lipid homeostasis and cellular maintenance processes. The findings from the new study, published in The American Journal of Pathology, have the potential to inform new therapeutic strategies and improve outcomes for NAFLD patients.

Two studies led by researchers at the Broad Institute of MIT and Harvard and Mass General Brigham have greatly expanded the number of known genetic variants that boost the risk for atrial fibrillation (AF), a common heart condition marked by an irregular heartbeat that can lead to stroke and heart failure.